Immune checkpoint inhibitor colitis, a rising issue in targeted cancer therapy era: A literature review Cover

.blurhash-client-img { display: none !important; }

Immune checkpoint inhibitor colitis, a rising issue in targeted cancer therapy era: A literature review

Romanian Journal of Internal Medicine

Volume 62 (2024): Issue 3 (September 2024)

By: Randy Adiwinata, Kevin Tandarto, Caroline Tanadi, Bradley Jimmy Waleleng, Harlinda Haroen, Linda Rotty, Fandy Gosal, Luciana Rotty, Cecilia Hendratta, Pearla Lasut, Jeanne Winarta, Andrew Waleleng, Paulus Simadibrata and Marcellus Simadibrata

Open Access

|Apr 2024

Authors

Randy Adiwinata

randyadiwinata@yahoo.com

Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi “Prof. dr. R. D. Kandou” Hospital, Manado, Indonesia

Gastrointestinal Cancer Center, MRCCC Siloam Hospital Semanggi, Jakarta, Indonesia

Kevin Tandarto

Intensive Care Unit, Columbia Asia Hospital, Semarang, Indonesia

Caroline Tanadi

Medical Doctor, St. Carolus Hospital, Jakarta, Indonesia

Bradley Jimmy Waleleng

Division of Gastroenterology-Hepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi “Prof. dr. R. D. Kandou” Hospital, Manado, Indonesia

Harlinda Haroen

Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi/Prof. dr. R. D. Kandou Hospital, Manado, Indonesia

Linda Rotty

Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi/Prof. dr. R. D. Kandou Hospital, Manado, Indonesia

Fandy Gosal

Division of Gastroenterology-Hepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi “Prof. dr. R. D. Kandou” Hospital, Manado, Indonesia

Luciana Rotty

Division of Gastroenterology-Hepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi “Prof. dr. R. D. Kandou” Hospital, Manado, Indonesia

Cecilia Hendratta

Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi/Prof. dr. R. D. Kandou Hospital, Manado, Indonesia

Pearla Lasut

Division of Hematology and Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi/Prof. dr. R. D. Kandou Hospital, Manado, Indonesia

Jeanne Winarta

Division of Gastroenterology-Hepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi “Prof. dr. R. D. Kandou” Hospital, Manado, Indonesia

Andrew Waleleng

Division of Gastroenterology-Hepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sam Ratulangi “Prof. dr. R. D. Kandou” Hospital, Manado, Indonesia

Paulus Simadibrata

Gastrointestinal Cancer Center, MRCCC Siloam Hospital Semanggi, Jakarta, Indonesia

Abdi Waluyo Hospital, Jakarta, Indonesia

Marcellus Simadibrata

Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia

DOI: https://doi.org/10.2478/rjim-2024-0015 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749

Journal RSS Feed

Language: English

Page range: 219 - 230

Submitted on: Nov 29, 2023

Published on: Apr 9, 2024

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Immune checkpoint inhibitors,

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Gastroenterology,

© 2024 Randy Adiwinata, Kevin Tandarto, Caroline Tanadi, Bradley Jimmy Waleleng, Harlinda Haroen, Linda Rotty, Fandy Gosal, Luciana Rotty, Cecilia Hendratta, Pearla Lasut, Jeanne Winarta, Andrew Waleleng, Paulus Simadibrata, Marcellus Simadibrata, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 62 (2024): Issue 3 (September 2024)Next article